Table 2 Results of one-way ANOVA and Kruskal–Wallis tests in healthy control (HC) subjects only (a) across all 3 age groups, and (b) across the 2 age groups with predominantly premenopausal subjects (age ≤50 years)
From: Illness progression in chronic fatigue syndrome: a shifting immune baseline
(a) HC all age groups | (b) HC groups age ≤50 years only | |||
|---|---|---|---|---|
| Â | p ANOVA | p Kruskalwallis | p ANOVA | p Kruskalwallis |
BMI | 0.00 | 0.01 | 0.00 | 0.00 |
 IL-1α | 0.23 | 0.04 | 0.12 | 0.12 |
 IL-1β | 0.00 | 0.00 | 0.00 | 0.00 |
 IL-2 | 0.27 | 0.01 | 0.32 | 0.02 |
 IL-4 | 0.00 | 0.00 | 0.18 | 0.01 |
 IL-5 | 0.00 | 0.00 | 0.00 | 0.00 |
 IL-6 | 0.99 | 0.89 | 0.91 | 0.95 |
 IL-8 | 0.08 | 0.01 | 0.27 | 0.06 |
 IL-10 | 0.00 | 0.00 | 0.00 | 0.00 |
 IL-12p70 | 0.00 | 0.00 | 0.02 | 0.01 |
 IL-13 | 0.00 | 0.00 | 0.00 | 0.00 |
 IL-15 | 0.22 | 0.04 | 0.98 | 0.41 |
 IL-17 | 0.00 | 0.00 | 0.00 | 0.01 |
 IL-23 | 0.00 | 0.00 | 0.00 | 0.00 |
 IFNγ | 0.02 | 0.02 | 0.00 | 0.01 |
 TNFα | 0.89 | 0.33 | 0.82 | 0.17 |
 LTα | 0.11 | 0.75 | 0.09 | 0.67 |